Novo Holdings is seeking a Partner (medtech) to join the Venture Investments team in our San Francisco office.

The successful candidate will be part of our team responsible for originating, analyzing, and managing our medtech investments. Our private and public investing activities implement a long-only strategy focused on small and mid-cap biotech and medtech companies driven by science, data, and a long-term view. Efforts in this area are primarily focused on pre-clinical and clinical-stage biotechnology companies as well as high-growth revenue-stage medical technology opportunities. We have a broad mandate to invest in crossover, IPO, follow-on financings, PIPEs, and open market transactions. Specific responsibilities may include, but are not limited to, the following:

• Identify new medtech investment opportunities that fit the Novo Holdings investment criteria
• Conduct initial meetings with companies to identify which merit further diligence work
• Following the internal Venture Investments procedure, promote worthwhile companies to high-priority cases. Lead the assessment of management teams, science, clinical development plans, regulatory outlook, commercial opportunities, intellectual property, competitive landscape, and valuation analysis to help determine the overall attractiveness of potential investment opportunities
• Negotiate terms and draft term sheets for those investments that Ventures Investments decides to make
• Syndicate investments with investment partners
• Working with external legal advisors and Novo Holdings’ legal department to complete legal documentation for investments
• Prepare mandates as required for Novo Holdings' approval of investments
• Take board seats on portfolio company boards and work with these portfolio companies to maximize their chances of success and so generate financial returns for Novo Holdings. This will typically involve participation in various board subcommittees as well as in general board meetings
• Periodically assess the merits of further investments in portfolio companies judging whether further (follow-on) investments are justified and negotiate terms of such investments
• Working with portfolio company board members, seek exits that will maximize ROI and, following negotiation, prepare exit mandates seeking the approval of such exits from Novo Holdings
• Train and mentor junior team members